Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Age Ageing ; 42(3): 324-30, 2013 May.
Artigo em Inglês | MEDLINE | ID: mdl-23612864

RESUMO

INTRODUCTION: the Qmci is a sensitive and specific test to differentiate between normal cognition (NC), mild cognitive impairment (MCI) and dementia. We compared the sensitivity and specificity of the subtests of the Qmci to determine which best discriminated NC, MCI and dementia. OBJECTIVE: the objective was to determine the contribution each subtest of the Qmci makes, to its sensitivity and specificity in differentiating MCI from NC and dementia, to refine and shorten the instrument. METHODS: existing data from our previous study of 965 subjects, testing the Qmci, was analysed to compare the sensitivity and specificity of the Qmci subtests. RESULTS: all the subtests of the Qmci differentiated MCI from NC. Logical memory (LM) performed the best (area under the receiver operating curve of 0.80), registration the worst, (0.56). LM and verbal fluency had the largest median differences (expressed as percentage of total score) between MCI and NC, 20 and 25%, respectively. Other subtests did not have clinically useful differences. LM was best at differentiating MCI from NC, irrespective of age or educational status. CONCLUSION: the Qmci incorporates several important cognitive domains making it useful across the spectrum of cognitive impairment. LM is the best performing subtest for differentiating MCI from NC.


Assuntos
Cognição , Disfunção Cognitiva/diagnóstico , Demência/diagnóstico , Testes Neuropsicológicos , Idoso , Área Sob a Curva , Estudos de Casos e Controles , Distribuição de Qui-Quadrado , Disfunção Cognitiva/psicologia , Demência/psicologia , Diagnóstico Diferencial , Função Executiva , Feminino , Humanos , Masculino , Memória , Valor Preditivo dos Testes , Desempenho Psicomotor , Curva ROC
2.
Age Ageing ; 37(2): 138-41, 2008 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-18349010

RESUMO

Inappropriate prescribing (IP) is a common and serious global healthcare problem in elderly people, leading to increased risk of adverse drug reactions (ADRs), polypharmacy being the main risk factor for both IP and ADRs. IP in older people is highly prevalent but preventable; hence screening tools for IP have been devised, principally Beers' Criteria and the Inappropriate Prescribing in the Elderly Tool (IPET). Although Beers' Criteria have become the most widely cited IP criteria in the literature, nevertheless, they have serious deficiencies, including several drugs that are rarely prescribed nowadays, a lack of structure in the presentation of the criteria and omission of several important and common IP instances. New, more up-to-date, systems-based and easily applicable criteria are needed that can be applied in the routine clinical setting.


Assuntos
Envelhecimento/efeitos dos fármacos , Prescrições de Medicamentos/normas , Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos , Erros de Medicação/estatística & dados numéricos , Sistemas de Notificação de Reações Adversas a Medicamentos/organização & administração , Idoso , Idoso de 80 Anos ou mais , Envelhecimento/fisiologia , Relação Dose-Resposta a Droga , Prescrições de Medicamentos/estatística & dados numéricos , Uso de Medicamentos/normas , Uso de Medicamentos/estatística & dados numéricos , Feminino , Avaliação Geriátrica/métodos , Humanos , Incidência , Irlanda , Masculino , Avaliação das Necessidades , Padrões de Prática Médica , Medição de Risco
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA